GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6-Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6-Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering
Authors
Keywords
-
Journal
DIABETES
Volume 63, Issue 10, Pages 3221-3229
Publisher
American Diabetes Association
Online
2014-06-20
DOI
10.2337/db14-0100
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans
- (2013) Katja Piotrowski et al. Cardiovascular Diabetology
- Elevated plasma GLP-1 levels and enhanced expression of cardiac GLP-1 receptors as markers of left ventricular systolic dysfunction: a cross-sectional study
- (2013) Arihiro Hattori et al. BMJ Open
- Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
- (2012) Swenja Kröller-Schön et al. CARDIOVASCULAR RESEARCH
- Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
- (2012) Judith Jacobi et al. CRITICAL CARE MEDICINE
- Intensive versus conventional glucose control in critically ill patients: A meta-analysis of randomized controlled trials
- (2012) Yan Ling et al. European Journal of Internal Medicine
- Local and systemic response to intramammary lipopolysaccharide challenge during long-term manipulated plasma glucose and insulin concentrations in dairy cows
- (2012) M.C.M.B. Vernay et al. JOURNAL OF DAIRY SCIENCE
- Hypoglycemia and Risk of Death in Critically Ill Patients
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1-Stimulated Postprandial Insulin Secretion in Humans
- (2011) M. Salehi et al. DIABETES
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
- (2010) Minako Yamaoka-Tojo et al. Cardiovascular Diabetology
- GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats
- (2010) Hui-Chun Ku et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward
- (2009) A. Turchin et al. DIABETES CARE
- Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor κb pathway
- (2009) Carl F. Raetzsch et al. HEPATOLOGY
- Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction
- (2009) Mikhail Kosiborod JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Intensive versus Conventional Glucose Control in Critically Ill Patients
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation
- (2009) Kristopher C. Dozier et al. PEPTIDES
- Glucometrics in Patients Hospitalized With Acute Myocardial Infarction
- (2008) Mikhail Kosiborod et al. CIRCULATION
- Glucose Metabolism and Insulin Resistance in Sepsis
- (2008) S. Van Cromphaut et al. CURRENT PHARMACEUTICAL DESIGN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now